PT4021487T - Péptidos antigénicos para prevenir e tratar neoplasia maligna de células b - Google Patents

Péptidos antigénicos para prevenir e tratar neoplasia maligna de células b

Info

Publication number
PT4021487T
PT4021487T PT208042796T PT20804279T PT4021487T PT 4021487 T PT4021487 T PT 4021487T PT 208042796 T PT208042796 T PT 208042796T PT 20804279 T PT20804279 T PT 20804279T PT 4021487 T PT4021487 T PT 4021487T
Authority
PT
Portugal
Prior art keywords
prevention
treatment
antigenic peptides
cell malignancy
malignancy
Prior art date
Application number
PT208042796T
Other languages
English (en)
Original Assignee
Enterome S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enterome S A filed Critical Enterome S A
Publication of PT4021487T publication Critical patent/PT4021487T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001111—Immunoglobulin superfamily
    • A61K39/001112—CD19 or B4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001111—Immunoglobulin superfamily
    • A61K39/001113—CD22, BL-CAM, siglec-2 or sialic acid- binding Ig-related lectin 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001116—Receptors for cytokines
    • A61K39/001117—Receptors for tumor necrosis factors [TNF], e.g. lymphotoxin receptor [LTR] or CD30
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001124—CD20
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001129—Molecules with a "CD" designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
PT208042796T 2019-11-15 2020-11-13 Péptidos antigénicos para prevenir e tratar neoplasia maligna de células b PT4021487T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19306475 2019-11-15

Publications (1)

Publication Number Publication Date
PT4021487T true PT4021487T (pt) 2024-02-02

Family

ID=69190588

Family Applications (1)

Application Number Title Priority Date Filing Date
PT208042796T PT4021487T (pt) 2019-11-15 2020-11-13 Péptidos antigénicos para prevenir e tratar neoplasia maligna de células b

Country Status (1)

Country Link
PT (1) PT4021487T (pt)

Similar Documents

Publication Publication Date Title
FI4021487T3 (fi) Antigeenisiä peptidejä b-solun pahanlaatuisuuden ehkäisyyn ja hoitoon
FI3773689T3 (fi) Antigeenisiä peptidejä syövän ehkäisyyn ja hoitoon
GB201804514D0 (en) Treatment of pyroptosis
IL279347A (en) Gremlin-1 antagonist for cancer prevention and treatment
IL285807A (en) Immunotherapy for cancer treatment
SG11202006160RA (en) Ipsc-based vaccine as a prophylactic and therapeutic treatment for cancer
IL290130A (en) Treatment of insidious tumors in the immune system
GB201804515D0 (en) Treatment of necroptosis
IL281997A (en) Combined treatment for the treatment of uveal melanoma
GB201916428D0 (en) Treatment of hydro-carbon-contaminated materials
SG11202100700VA (en) Immune modifying particles for the treatment of cancer
PT4021487T (pt) Péptidos antigénicos para prevenir e tratar neoplasia maligna de células b
IL290656A (en) Lorbinectadine in the treatment of malignant mesothelioma
IL280262A (en) Compositions and methods for treating cancer
EP3987032A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
GB201810635D0 (en) Peptides and cancer treatment
IL285458A (en) Combined therapy for the treatment of b-cell malignancies
IL288433A (en) Peroxidase-3 activation and immunotherapy for cancer treatment
EP4084822A4 (en) INDIVIDUALIZED VACCINES FOR THE TREATMENT AND PREVENTION OF CANCERS
GB201917493D0 (en) methods for the treatment of uveal melanoma
GB201815694D0 (en) Prevention and treatment of cancer
GB201809946D0 (en) Prevention and treatment of cancer
IL271738A (en) Tumor treatment device
IL281091A (en) Peptide therapy for cancer treatment and their uses
GB201918853D0 (en) Methods of treatment